The professor of clinical neuroscience at Newcastle University discussed selecting appropriate and representative patient populations across different phases of clinical trials for Parkinson disease. [WATCH TIME: 5 minutes]
Camille Carroll, MD
Advertisement
Professor of clinical neuroscience at Newcastle University.
Articles by Camille Carroll, MD
Advertisement
Latest Updated Articles
Rethinking Inclusion Criteria to Increase Generalizability, Patient Participation in Parkinson Disease Trials: Camille Carroll, MDPublished: October 28th 2025 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
New 3-Year EMBARK Data Highlights Continued Therapeutic Effect of Gene Therapy Elevidys in Duchenne
2
FDA Lifts Clinical Hold on Intellia’s Trial for Gene Editing Therapy Nex-Z in ATTRv-PN, Places Holds on REGENXBIO MPS Trials
3
Phase 2 Study of Lenadogene Nolparvovec Gene Therapy for Leber Hereditary Optic Neuropathy: The REVISE Trial
4
Priority Review Granted for Weekly Subcutaneous Lecanemab Dosing in Early Alzheimer Disease
5